Issue
Alert me when new journal issues are available via or via
Guest Editorials
Use of biological response modifiers to enhance the action of Rituximab Ronald P. Taylor pages 599-600 Full Text | Full-Text PDF (51 KB)
Complex and simple Ephraim Philip Lansky, Daniel D. Von Hoff pages 601-602 Full Text | Full-Text PDF (45 KB)
Trying to improve clinical outcome in AML: Lessons from negative trials Judith E. Karp, B. Douglas Smith pages 603-604 Full Text | Full-Text PDF (40 KB)
The rationale engineering of BCR/ABL blockers: an answer to STI571 acquired resistance in leukemia treatment Ireneusz J. Majsterek pages 605-606 Full Text | Full-Text PDF (45 KB)
Curing acute myelogenous leukemia: Still a major challenge B. Douglas Smith, Judith E. Karp pages 607-608 Full Text | Full-Text PDF (41 KB)
Clinical Studies
High dose intermittent ARA-C (HiDAC) for consolidation of patients with de novo AML: a single center experience Alexandra Böhm, Maria Piribauer, Friedrich Wimazal, Klaus Geissler, Heinz Gisslinger, Paul Knöbl, Ulrich Jäger, Christa Fonatsch, Paul A. Kyrle, Peter Valent, Klaus Lechner, Wolfgang R. Sperr pages 609-615 Abstract | Full Text | Full-Text PDF (117 KB)
Prognostic significance of FLT3 mutations in pediatric non-promyelocytic acute myeloid leukemia Hyoung Jin Kang, Seung-Hee Hong, In Hoo Kim, Byung-Kiu Park, Kyou Sup Han, Han Ik Cho, Hee Young Shin, Hyo Seop Ahn pages 617-623 Abstract | Full Text | Full-Text PDF (180 KB)
Therapy-related myelodysplastic syndrome in childhood: A retrospective study of 36 patients in Japan M. Tsurusawa, A. Manabe, Y. Hayashi, Y. Akiyama, H. Kigasawa, H. Inada, Y. Noguchi, N. Sawai, R. Kobayashi, Y. Nagatoshi, K. Kawakami, S. Kojima, T. Nakahata, MDS committee of the Japanese Society of Pediatric Hematology pages 625-632 Abstract | Full Text | Full-Text PDF (109 KB)
TEL/AML1 and immunoreceptor gene rearrangements—which comes first? Jan Zuna, Ondrej Krejci, Jozef Madzo, Eva Fronkova, Lucie Sramkova, Ondrej Hrusak, Tomas Kalina, Martina Vaskova, Jan Stary, Jan Trka, The Czech Paediatric Haematology Working Group (CPH) pages 633-639 Abstract | Full Text | Full-Text PDF (155 KB)
Thalidomide treatment reduces apoptosis levels in bone marrow cells from patients with myelodysplastic syndromes Rosangela Invernizzi, Erica Travaglino, Mara De Amici, Silvia Brugnatelli, Isabella Ramajoli, Bianca Rovati, Chiara Benatti, Edoardo Ascari pages 641-647 Abstract | Full Text | Full-Text PDF (145 KB)
Adaptive randomized study of idarubicin and cytarabine alone or with interleukin-11 as induction therapy in patients aged 50 or above with acute myeloid leukemia or high-risk myelodysplastic syndromes Francis J. Giles, Hagop M. Kantarjian, Jorge E. Cortes, Stephan Faderl, Srdan Verstovsek, Deborah Thomas, Guillermo Garcia-Manero, William Wierda, Alessandra Ferrajoli, Stephen Kornblau, Gloria N. Mattiuzzi, Apostolia M. Tsimberidou, Maher Albitar, Susan M. O’Brien, Elihu Estey pages 649-652 Abstract | Full Text | Full-Text PDF (69 KB)
Methylation of p15INK4b and E-cadherin genes is independently correlated with poor prognosis in acute myeloid leukemia Takashi Shimamoto, Junko H. Ohyashiki, Kazuma Ohyashiki pages 653-659 Abstract | Full Text | Full-Text PDF (131 KB)
Analysis of HFE and TFR2 gene mutations in patients with acute leukemia Dino Veneri, Massimo Franchini, Mauro Krampera, Giovanna de Matteis, Pietro Solero, Giovanni Pizzolo pages 661-664 Abstract | Full Text | Full-Text PDF (65 KB)
Irregular nuclear shape of bone marrow plasma cells defines a multiple myeloma subgroup related to hypodiploidy and to short survival Xavier Leleu, Franck Genevieve, Romain Guieze, Alain Duhamel, Joris Andrieux, Celine Berthon, Alban Godon, Sophie Prat-Lesaffre, Stephane Depil, Jean-Luc Lai, Thierry Facon, Marc Zandecki, On behalf of the Intergroupe Francophone du Myelome (IFM) pages 665-671 Abstract | Full Text | Full-Text PDF (195 KB)
A morphometric approach for the evaluation of angiogenesis in acute lymphoblastic leukemia of childhood Lida Kalmanti, Konstantina Dampaki, Helen Dimitriou, Eftichia Stiakaki, Vretos Chaniotis, Efstathios Stathopoulos pages 673-677 Abstract | Full Text | Full-Text PDF (206 KB)
Laboratory Studies
Rituximab therapy of lymphoma is enhanced by orally administered (1→3),(1→4)-d-β-glucan Shakeel Modak, Guenther Koehne, Andrew Vickers, Richard J. O’Reilly, Nai-Kong V. Cheung pages 679-683 Abstract | Full Text | Full-Text PDF (218 KB)
Pycnogenol induces differentiation and apoptosis in human promyeloid leukemia HL-60 cells W.W. Huang, J.S. Yang, C.F. Lin, W.J. Ho, M.R. Lee pages 685-692 Abstract | Full Text | Full-Text PDF (333 KB)
Engineering 3-alkyltriazenes to block bcr-abl kinase: a novel strategy for the therapy of advanced bcr-abl expressing leukemias Athanasia Katsoulas, Zakaria Rachid, Fouad Brahimi, James McNamee, Bertrand J. Jean-Claude pages 693-700 Abstract | Full Text | Full-Text PDF (412 KB)
Acute myeloid leukemia cell lines MOLM-17 and MOLM-18 derived from patient with advanced myelodysplastic syndromes Yoshinobu Matsuo, Hans G. Drexler, Akira Harashima, Ayumi Okochi, Kensuke Kojima, Shoji Asakura, Mitsune Tanimoto, Kunzo Orita pages 701-710 Abstract | Full Text | Full-Text PDF (383 KB)
Brief Communication
Immune evasion strategies of pediatric precursor-B acute lymphoblastic leukemia after allogeneic bone marrow transplantation—a case study Draga Barbaric, Kristin Wynne, Soudabeh Aslanian, Mason Bond, Gregor S.D. Reid pages 711-714 Abstract | Full Text | Full-Text PDF (93 KB)
Case of the Month
Multiple myeloma presenting initially as a solitary pleural effusion later complicated by malignant plasmacytic ascites Yoshio Inoue, Kathrina Chua, Rebecca F. McClure, Manuel C. Jimenez, Christopher D. Gocke, Ashraf Z. Badros, Naoko Takebe pages 715-718 Abstract | Full Text | Full-Text PDF (73 KB)
Letters to the Editor
Late-onset marrow aplasia due to imatinib in newly diagnosed chronic phase chronic myeloid leukaemia Wee J. Chng, Leonard H.C. Tan pages 719-720 Full Text | Full-Text PDF (147 KB)
All-trans retinoic acid related headache in patients with acute promyelocytic leukemia: prophylaxis and treatment with acetazolamide Siddhartha Ganguly page 721 Full Text | Full-Text PDF (34 KB)
Copyright © 2010 Elsevier, Inc. All rights reserved | Privacy Policy | Terms & Conditions | Feedback | About Us | Help | Contact Us | The content on this site is intended for health professionals.
